• Department of Respiratory and Critical Care Medicine, Medical Center of Chinese People’s Armed Police Force, Tianjing 300162, P. R. China;
LIU Bin, Email: 13820931847@163.com
Export PDF Favorites Scan Get Citation

Objective To analyze the clinical characteristics of patients with amyopathic dermatomyositis with organizing pneumonia (ADM-OP).Methods The clinical data of 8 patients hospitalized with ADM-OP from June 2014 to June 2018 were retrospectively reviewed and simultaneously compared with those of 8 patients of cryptogenic organizing pneumonia (COP).Results The incidence of skin lesion, Gottron’s sign, mechanic’s hand and positive anti-synthase antibodies in the ADM-OP patients were 87.5%, 87.5% 75.0% and 87.5% respectively. Gender, smoking, respiratory symptoms and signs, arterial partial pressure of oxygen, arterial partial pressure of carbon dioxide and treatment strategy were no statistical difference between ADM-OP and COP patients, but the onset age and Chest CT fibrosis scores (CTFS) on admission existed differences. After treatment for 3 months, CTFS, rate of change and forced vital capacity (FVC) existed differences. After treatment for 6 months, CTFS, rate of change, FVC and diffusing capacity of the lung for carbon monoxide existed differences.Conclusions Skin lesion, Gottron’s sign, mechanic’s hand and positive anti-synthase antibodies are more common in ADM-OP patients. Their response to treatment is good but the improvement rates in CTFS and pulmonary function are slower than those of COP patients.

Citation: LI Xueren, PENG Shouchun, WANG Liping, LIU Bin. Clinical characteristics of amyopathic dermatomyositis with organizing pneumonia. Chinese Journal of Respiratory and Critical Care Medicine, 2019, 18(2): 140-143. doi: 10.7507/1671-6205.201810011 Copy

  • Previous Article

    Lung transplantation for interstitial lung disease : benefits and prognostic factors
  • Next Article

    Cardiac valve replacement improves sleep quality in patients with rheumatic valvular heart disease and central sleep apnea